Search Form
First, enter a politician or zip code
Now, choose a category

Public Statements

Public Statements

Date Title Officials Location
Jan. 25, 2017 Grassley on Bipartisan Legislation to Help Fight Dangerous Synthetic Drugs Sen. Charles Grassley Washington, DC
Jan. 4, 2017 Letter to The Hon. Andrew M. Slavitt, Acting Administrator of Centers for Medicare & Medicaid Services - Pressing Administration on EpiPen, Dliaudid, Prilosec Misclassifications Sen. Charles Grassley Washington, DC
Dec. 13, 2016 Letter to President-Elect Donald J. Trump - Prioritize Fixing Medicaid Drug Misclassifications Sen. Charles Grassley Washington, DC
Dec. 9, 2016 Grassley: Watchdog is Right to Review Misclassifications Under Medicaid Drug Rebate Program Sen. Charles Grassley Unknown
Dec. 8, 2016 Grassley, HHS Secretary Nominee Price Discuss Rural Hospitals, Medicaid Oversight, Soaring Drug Prices and Remedies Sen. Charles Grassley Unknown
Dec. 7, 2016 EpiPen Misclassification is Case Study in What Not to Do, Grassley Tells CMS Administrator Nominee Sen. Charles Grassley Unknown
Dec. 6, 2016 Grassley Continues Push to Combat Rising Drug Prices Sen. Charles Grassley Washington, DC
Nov. 17, 2016 Administration Takes Steps to Implement Key Medication-assisted Treatment Provision in Grassley-Led Opioid Treatment Bill Sen. Charles Grassley Washington, DC
Oct. 19, 2016 Grassley Encourages Iowans to Participate in Prescription Drug Take Back Day This Saturday Sen. Charles Grassley Washington, DC
Oct. 14, 2016 Letter to the Hon. Andrew Slavitt, Acting Administrator, Centers for Medicare and Medicaid Services - Expanded Substance Abuse Treatment Coverage to Combat Opioid Crisis Rep. Rod Blum Washington, DC
Oct. 11, 2016 Grassley Presses Justice Department for Details of Mylan Settlement Over EpiPen Overcharges Sen. Charles Grassley Washington, DC
Oct. 6, 2016 EpiPens: Grassley Finds Substantial Revenue Growth to Mylan from Taxpayers Via Medicare, Medicaid Sen. Charles Grassley Unknown
Oct. 4, 2016 Grassley Presses EpiPen Maker, Federal Agency on Medicaid Classification Sen. Charles Grassley Washington, DC
Sept. 20, 2016 Letter to the Honorable Daniel Levinson, Inspector General of the Dept. of Health and Human Services - Call for Review of Rebate Practices for Mylan's EpiPen Sen. Charles Grassley Washington, DC
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service Sen. Charles Grassley Washington, DC
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service Sen. Joni Ernst Washington, DC
Aug. 29, 2016 EpiPen Maker Announces Generic Product; Grassley Looks Forward to Details, Written Responses to His Inquiries Sen. Charles Grassley Unknown
Aug. 24, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration - Account for Any Alternatives to the EpiPen Amid Product Cost Increase Sen. Charles Grassley Unknown
Aug. 4, 2016 Letter to Chuck Rosenberg, Acting Administrator of the Drug Enforcement Administration - Request Update on DEA Efforts to Monitor Controlled Substances Prescribers Sen. Charles Grassley Washington, DC
July 22, 2016 Landmark Addiction Recovery Bill Signed into Law Sen. Charles Grassley Washington, DC
July 15, 2016 Grassley, Schumer Bill Bans Dangerous & Deceptive Synthetic Drugs Sen. Charles Grassley Washington, DC
July 13, 2016 Senate Sends Landmark Addiction Recovery Bill to President Sen. Charles Grassley Washington, DC
July 13, 2016 Ernst Supports Bipartisan Comprehensive Addiction and Recovery Act Sen. Joni Ernst Washington, DC
July 12, 2016 Comprehensive Addiction and Recovery Act of 2016--Conference Report-- Sen. Charles Grassley Washington, DC
July 8, 2016 Grassley Statement on House Passage of Bipartisan Addiction Recovery Bill Sen. Charles Grassley Washington, DC
July 7, 2016 House-Senate Opioid Conference Report Finalized Sen. Charles Grassley Washington, DC
July 6, 2016 Grassley Leads Senate Delegation Finalizing Landmark Addiction Recovery Bill Sen. Charles Grassley Washington, DC
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic Sen. Charles Grassley Washington, DC
June 27, 2016 Letter to the Honorable Jeh Johnson, Secretary of Homeland Security - Undocumented Criminal Sen. Charles Grassley Washington, DC
June 22, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on Oversight of the Drug Enforcement Administration Sen. Charles Grassley Washington, DC
June 16, 2016 Finance Senators Introduce Family First Prevention Services Act Sen. Charles Grassley Washington, DC
June 14, 2016 Letter to the Honorable Sylvia Mathews Burwell, Secretary of the US Department of Health and Human Services - Call for Affordable Medical Treatment for Opioid Dependency Rep. Rod Blum Washington, DC
June 7, 2016 Hearing of the Senate Judiciary Committee - Chairman's Statement on "Deadly Synthetic Drugs: The Need to Stay Ahead of the Poison Peddlers" Sen. Charles Grassley Washington, DC
May 31, 2016 Letter to Gene Dodaro, Comptroller General of the United States, Government Accountability Office - Financial Technology Marketplace Sen. Joni Ernst Washington, DC
May 17, 2016 Grassley Seeks Answers on Wasted $86 Million for Drug Interdiction Plane for Afghanistan Sen. Charles Grassley Washington, DC
May 17, 2016 Two More Judiciary Committee Bills Signed into Law Sen. Charles Grassley Washington, DC
May 16, 2016 Grassley, Feinstein Seek Update on Agencies' Scientific, Medical Evaluation of Cannabidiol Sen. Charles Grassley Washington, DC
May 13, 2016 The Des Moines Register - Opioid Epidemic Needs Collaboration, Thoughtful Approach Rep. David Young Unknown
May 10, 2016 Grassley, Feinstein Praise House Passage of Bill to Fight Transnational Drug Trafficking; Bill Heads to President's Desk Sen. Charles Grassley Washington, DC
May 10, 2016 Grassley, Klobuchar Introduce Bill to Protect Classified Information Used to Designate Foreign Narcotics Kingpins Sen. Charles Grassley Washington, DC
May 4, 2016 Letter to the Hon. Paul Ryan, Speaker of the House - Consider Emergency Funding To Address Opioid And Heroin Epidemic Rep. David Loebsack Washington, DC
April 28, 2016 National Prescription Drug Take Back Day Sen. Charles Grassley Washington, DC
April 27, 2016 Hearing of the Senate Judiciary Committee - Chairman Grassley's Opening Statement on "Counterfeits and Their Impact on Consumer Health and Safety" Sen. Charles Grassley Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Rep. Steve King Washington, DC
April 26, 2016 Letter to Dr. Robert M. Califf, Commissioner of the Food and Drug Administration (FDA) - Sen. Cruz, Others Hammer FDA on Relaxed Standards for Abortion Drug Sen. Joni Ernst Washington, DC
April 15, 2016 Grassley, Feinstein Urge CMS to Press Hospitals on Avoiding Unnecessary Opioids Sen. Charles Grassley Washington, DC
April 4, 2016 Defend Trade Secrets Act of 2015 Sen. Charles Grassley Washington, DC
March 31, 2016 Letter to Gene Dodarco, Comptroller General of the United States, Government Accountability Office - Federal Drug Take Back Programs Sen. Charles Grassley Washington, DC
March 29, 2016 Administration Too Slow on Certain Anti-opioid Measures, Sends Mixed Message on Marijuana Sen. Charles Grassley Unknown
March 29, 2016 Administration Too Slow on Certain Anti-opioid Measures, Sends Mixed Message on Marijuana Sen. Charles Grassley Unknown
March 10, 2016 Senate Accomplishments Sen. Charles Grassley Washington, DC
March 10, 2016 Ernst Applauds Comprehensive Addiction and Recovery Act Passage Sen. Joni Ernst Washington, D.C.
March 10, 2016 Comprehensive Addiction and Recovery Act of 2015 Sen. Charles Grassley Washington, DC
March 10, 2016 Grassley Leads Bipartisan Addiction Recovery Bill to Passage in Senate Sen. Charles Grassley Unknown
March 3, 2016 Comprehensive Addiction and Recovery Act of 2015 Sen. Charles Grassley Washington, DC
March 2, 2016 Comprehensive Addiction and Recovery Act of 2015 Sen. Charles Grassley Washington, DC
Feb. 29, 2016 Comprehensive Addiction and Recovery Act of 2015--Motion to Proceed Sen. Charles Grassley Washington, DC
Feb. 23, 2016 Grassley, McConnell Bill Would Help Foster Children Affected by Opioids, Methamphetamine, Other Substance Abuse Sen. Charles Grassley Washington, DC
Feb. 11, 2016 Judiciary Committee Advances Bipartisan Effort to Address National Opioid Epidemic Sen. Charles Grassley Washington, DC
Feb. 11, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Executive Business Meeting Sen. Charles Grassley Washington, DC
Jan. 28, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Executive Business Meeting Sen. Charles Grassley Washington, DC
Jan. 27, 2016 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on "Attacking America's Epidemic of Heroin and Prescription Drug Abuse" Sen. Charles Grassley Washington, DC
Jan. 27, 2016 Grassley Statement at a Judiciary Committee Hearing on Opioid Abuse Sen. Charles Grassley Unknown
Dec. 16, 2015 Grassley: Youth Drug Survey, Marijuana Results Disturbing Sen. Charles Grassley Unknown
Dec. 15, 2015 Data Behind the Sovaldi Report: Wyden-Grassley Investigation Looks at Drug Costs in Every State Medicaid Program Sen. Charles Grassley Washington, DC
Nov. 23, 2015 Grassley, McCain Urge Greater Importation of Prescription Drugs from Other Countries Sen. Charles Grassley Washington, DC
Oct. 21, 2015 Grassley on the White House Plan on Prescription Drug Abuse Sen. Charles Grassley Unknown
Oct. 8, 2015 Grassley, Feinstein Praise Senate Passage of Bill to Fight Transnational Drug Trafficking Sen. Charles Grassley Washington, DC
Oct. 8, 2015 Senate Passes Bill to Combat Transnational Drug Trafficking Sen. Charles Grassley Washington, DC
Oct. 6, 2015 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Grassley, Hearing on "A New Era in the Fight Against Methamphetamine in Iowa" Sen. Charles Grassley Des Moines, IA
Oct. 1, 2015 Senators Introduce Landmark Bipartisan Sentencing Reform and Corrections Act of 2015 Sen. Charles Grassley Washington, DC
Sept. 18, 2015 Grassley Welcomes More Access to Opioid Addiction Medicine Sen. Charles Grassley Unknown
Sept. 17, 2015 Grassley Statement at an Executive Business Meeting Sen. Charles Grassley Unknown
Sept. 17, 2015 Grassley Praises Committee Passage of Bill to Fight Transnational Drug Trafficking Sen. Charles Grassley Unknown
Sept. 10, 2015 Grassley: Drug Use Survey Results Are Disturbing Sen. Charles Grassley Unknown
July 30, 2015 Grassley Statement at an Executive Business Meeting Sen. Charles Grassley Unknown
July 27, 2015 Grassley Welcomes Re-instatement of Drug Take-back Program Sen. Charles Grassley Unknown
July 23, 2015 Goodlatte, Conyers, Grassley, Johnson Concerned About New Opinion that Denies Records to Inspectors General, Blocks Oversight, and Circumvents Congressional Intent Sen. Charles Grassley Washington, DC
July 14, 2015 Letter to Loretta Lynch, Attorney General - Executive Clemency for Drug Offenders Rep. Steve King Washington, DC
May 14, 2015 Grassley, Klobuchar, Graham, Feinstein Renew Efforts to Fight Synthetic Drugs Sen. Charles Grassley Unknown
May 14, 2015 Feinstein, Senators Renew Efforts to Fight Synthetic Drugs Sen. Charles Grassley Washington, DC
March 26, 2015 HHS Opioid Initiative Takes Positive Steps Sen. Charles Grassley Unknown
March 10, 2015 Morning Business Sen. Charles Grassley Washington, DC
March 4, 2015 Grassley, Feinstein Announce Drug Caucus Hearing on Controlled Substances Quota Process Sen. Charles Grassley Washington, DC
Feb. 12, 2015 Executive Session Sen. Charles Grassley Washington, DC
Jan. 7, 2015 Bill to Fight Transnational Drug Trafficking Sen. Charles Grassley Washington, DC
Jan. 6, 2015 Letter to John Kerry, Secretary of State, United States of America - Drug Policy Approach Sen. Charles Grassley Washington, DC
Jan. 6, 2015 Letter to Eric Holder, Attorney General of the United States of America - Drug Policy Approach Sen. Charles Grassley Washington, DC
Dec. 23, 2014 Feinstein, Grassley Release Recommendations for Combatting Afghan Drug Trade Sen. Charles Grassley Washington, DC
Dec. 19, 2014 Grassley on DEA Ban of New Types of Synthetic Drugs Sen. Charles Grassley Unknown
Dec. 15, 2014 Feinstein, Grassley Bill to Combat Transnational Drug Trafficking Passes Senate Sen. Charles Grassley Washington, DC
Oct. 29, 2014 Letter to Edith Ramirez, Chairwoman of the Federal Trade Commission - Urging Release of Data on Pay-for-Delay Settlements Sen. Charles Grassley Washington, DC
Aug. 26, 2014 Grassley Welcomes Investigation of DEA Payments to Amtrak Employee Sen. Charles Grassley Unknown
Aug. 7, 2014 Letter to Michele M. Leonhart, Administrator of the Drug Enforcement Administration - DEA Payment of $854,460 for Amtrak Passenger Information Sen. Charles Grassley Washington, DC
July 29, 2014 Detention of Daniel Chong Sen. Charles Grassley Washington, DC
July 28, 2014 Beyond the Fears of the Founding Fathers Rep. Steve King Washington, DC
July 10, 2014 Grassley Reacts to Findings in Inspector General Report on Drug Enforcement Administration's Alleged Mistreatment and Detainment of College Student Sen. Charles Grassley Unknown
June 24, 2014 Letter to Marilyn Tavenner, Administrator of the Centers for Medicare and Medicaid Services - The Effect of the Use of Patient Satisfaction Surveys on the Abuse of Prescription Opioid Pain Pain Relievers Sen. Charles Grassley Washington, DC
May 22, 2014 "Bad Habit" is Breaking Bad Sen. Charles Grassley Unknown
May 14, 2014 Hearing of the Senate Caucus on International Narcotics Control - America's Addiction to Opioids: Heroin and Prescription Drug Abuse Sen. Charles Grassley Unknown
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top